MARC record from Internet Archive

LEADER: 06253fam a2200409 a 4500
001 4056338
005 20221027025401.0
008 960725s1998 nyua b 001 0 eng c
010 $a 96029399
020 $a0195100247 (alk. paper)
035 $a(OCoLC)35209331
035 $a(OCoLC)ocm35209331
035 $9ANB9138HS
035 $a(NNC)4056338
035 $a4056338
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 10 $aRM300$b.P74 1998
060 10 $aQV 4 P957 1997
082 00 $a615/.7$220
245 00 $aPrinciples of medical pharmacology /$cedited by Harold Kalant, Walter H.E. Roschlau.
250 $a6th ed.
260 $aNew York :$bOxford University Press,$c1998.
300 $axviii, 957 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tIntroduction to General Pharmacology /$rH. Kalant --$g2.$tDrug Solubility, Absorption, and Movement Across Body Membranes /$rP. Seeman and H. Kalant --$g3.$tDrug Distribution /$rL. Endrenyi --$g4.$tDrug Biotransformation /$rD. S. Riddick --$g5.$tPharmacokinetics /$rL. Endrenyi --$g6.$tClearance: The Quantitative Basis of Dosage /$rL. Endrenyi --$g7.$tDrug Clearance by Specific Organs /$rL. Endrenyi --$g8.$tDose-Response Relationships /$rL. Endrenyi --$g9.$tDrug Receptors /$rJ. Mitchell and P. Seeman --$g10.$tSignal Transduction and Second Messengers /$rJ. Mitchell --$g11.$tSelectivity of Drug Action /$rH. Kalant --$g12.$tHuman Pharmacogenetics /$rW. Kalow and D. M. Grant --$g13.$tAutonomic Nervous System Neurotransmitters /$rC. Forster --$g14.$tAutonomic Cholinergic Agonists /$rL. Spero --$g15.$tAutonomic Cholinergic Antagonists /$rL. Spero --$g16.$tAdrenoceptor Agonists /$rC. Forster --$g17.$tAdrenoceptor Antagonists /$rC. Forster --
505 80 $g18.$tDrugs Acting on Adrenergic Neurons (Adrenergic Neuronal Blocking Drugs) /$rC. Forster --$g19.$tNeuromuscular Transmission and Drugs (Muscle Relaxants) /$rL. Spero --$g20.$tFunctional Organization of the Central Nervous System /$rA. J. Lanca --$g21.$tAgents Modifying Movement Control /$rW. M. Burnham --$g22.$tAntiseizure Drugs /$rW. M. Burnham --$g23.$tOpioid Analgesics and Antagonists /$rH. Kalant --$g24.$tGeneral Anesthetics /$rF. J. Carmichael and D. A. Haas --$g25.$tLocal Anesthetics /$rD. A. Haas and F. J. Carmichael --$g26.$tThe Alcohols /$rH. Kalant and J. M. Khanna --$g27.$tAnxiolytics and Hypnotics /$rE. M. Sellers, J. M. Khanna and M. K. Romach --$g28.$tAntipsychotics /$rS. Kapur and P. Seeman --$g29.$tAntidepressant and Mood Stabilizing Agents /$rJ. J. Warsh and J. M. Khanna --$g30.$tHallucinogens and Psychotomimetics /$rH. Kalant --$g31.$tThe Eicosanoids /$rC. R. Pace-Asciak and D. Kadar --$g32.$tAutacoids /$rD. Kadar --$g33.$tHistamine and Antihistamines /$rD. Kadar --
505 80 $g34.$tAnti-inflammatory Analgesics /$rD. Kadar --$g35.$tCardiovascular System Overview and Organization /$rU. Ackermann --$g36.$tDigitalis Glycosides and Other Positive Inotropic Agents /$rW. A. Mahon and C. Forster --$g37.$tAntiarrhythmic Drugs /$rP. Dorian --$g38.$tVasodilators /$rW. A. Mahon --$g39.$tHyperlipoproteinemias and Antihyperlipidemic Drugs /$rC. Forster --$g40.$tDrugs and the Respiratory System /$rW. A. Mahon --$g41.$tDiuretics /$rC. Whiteside and A. Marquez-Julio --$g42.$tDrugs Affecting Hemostasis /$rW. H. E. Roschlau --$g43.$tDrugs Affecting Erythropoiesis /$rW. H. E. Roschlau --$g44.$tPharmacotherapy of Acid-Peptic Disorders /$rE. A. Roberts --$g45.$tDrugs Used in the Treatment of Intestinal Motility Disorders and Inflammatory Disease /$rE. A. Roberts --$g46.$tDrugs, Alcohol, and the Liver /$rH. Kalant and E. A. Roberts --$g47.$tVasopressin, Oxytocin, and Uterotonic Drugs /$rS. R. George and B. P. Schimmer --
505 80 $g48.$tThyroid Hormones and Antihyperthyroid Drugs /$rB. P. Schimmer and S. R. George --$g49.$tGonadotropic and Gonadal Hormones /$rS. R. George and B. P. Schimmer --$g50.$tInsulin and Oral Hypoglycemic Drugs /$rB. P. Schimmer and S. R. George --$g51.$tAdrenocortical Steroid Hormones /$rB. P. Schimmer and S. R. George --$g52.$tPrinciples of Antimicrobial Therapy /$rJ. Uetrecht and S. L. Walmsley --$g53.$tAntimicrobial Agents That Act on Bacterial Cell Wall Formation /$rJ. Uetrecht and S. L. Walmsley --$g54.$tAntimicrobial and Antifungal Agents That Act on Cell Membranes /$rJ. Uetrecht and S. L. Walmsley --$g55.$tAntimicrobial Agents That Affect the Synthesis of Cellular Proteins /$rJ. Uetrecht and S. L. Walmsley --$g56.$tDrugs Affecting Cellular Nucleic Acid Synthesis /$rJ. Uetrecht and S. L. Walmsley --$g57.$tChemotherapy of Common Parasitic Infections /$rJ. S. Keystone --$g58.$tAntiviral Agents /$rS. L. Walmsley --$g59.$tAntiseptics, Disinfectants, and Sterilization /$rE. L. Ford-Jones --
505 80 $g60.$tAntineoplastic Drugs /$rM. J. Moore and G. J. Goldenberg --$g61.$tImmune System Organization, Modulation, and Pharmacology /$rJ. W. Semple and J. M. Brandwein --$g62.$tSources of Individual Variation in Drug Response /$rH. Kalant --$g63.$tAdverse Drug Reactions /$rC. A. Naranjo, N. H. Shear and U. Busto --$g64.$tDrug Interactions /$rE. M. Sellers and M. K. Romach --$g65.$tPerinatal Pharmacology /$rL. A. Magee and G. Koren --$g66.$tGeriatric Clinical Pharmacology /$rD. S. Sitar --$g67.$tVitamins /$rM. J. Baigent --$g68.$tDrugs Altering Bone Metabolism /$rW. C. Sturtridge --$g69.$tChemical Carcinogenesis /$rA. B. Okey and P. A. Harper --$g70.$tChemical Teratogenesis /$rP. G. Wells --$g71.$tBehavioral Pharmacology /$rL. A. Grupp and H. Kalant --$g72.$tDrug Abuse and Drug Dependence /$rH. Kalant and L. A. Grupp --$g73.$tPrinciples of Toxicology /$rM. A. McGuigan and P. G. Wells --$g74.$tPoisonings and Antidotal Therapy /$rM. A. McGuigan --
505 80 $g75.$tDrug Development and Regulations /$rC. A. Naranjo and E. Janecek.
650 0 $aPharmacology.$0http://id.loc.gov/authorities/subjects/sh85100599
650 12 $aPharmacology.$0https://id.nlm.nih.gov/mesh/D010600
700 1 $aKalant, Harold.$0http://id.loc.gov/authorities/names/n50042756
700 1 $aRoschlau, Walter H. E.$0http://id.loc.gov/authorities/names/n86808918
852 00 $boff,hsl$hRM300$i.P74 1998 Q